ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P 500
5,917.11
0.00%
US Tech 100
20,039.60
-0.43%
Dow Jones
43,408.47
0.32%
Brent Oil
73.395
0.76%
Bitcoin
97,587.27
3.42%
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. Eupraxia Pharmaceuticals Inc (EPRX) Quote

Eupraxia Pharmaceuticals Inc

Eupraxia Pharmaceuticals Inc (EPRX)

Eupraxia Pharmaceuticals Inc
3.60
0.34
(10.43%)
Closed November 20 4:00PM
Delayed by 15 minutes
3.60
0.00
( 0.00% )
Pre Market: 4:00AM
Delayed by 15 minutes

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Premium

Key stats and details

Current Price
3.60
Bid
2.50
Ask
5.87
Volume
16
0.00 Day's Range 0.00
2.20 52 Week Range 4.08
Market Cap
128.241M
Previous Close
3.60
Open
-
Last Trade
16
@
3.8
Last Trade Time
04:03:32
Financial Volume
-
VWAP
-
Average Volume (3m)
14,364
Shares Outstanding
35,622,553
Dividend Yield
-
PE Ratio
-6.35
Earnings Per Share (EPS)
-0.79
Revenue
-
Net Profit
-28.22M

About Eupraxia Pharmaceuticals Inc

Eupraxia Pharmaceuticals Inc is a clinical-stage biotechnology company focused on the development of locally delivered, extended-release alternatives to existing pharmaceuticals. Its product candidates address therapeutic areas with a high unmet medical need and strive to provide improved patient be... Eupraxia Pharmaceuticals Inc is a clinical-stage biotechnology company focused on the development of locally delivered, extended-release alternatives to existing pharmaceuticals. Its product candidates address therapeutic areas with a high unmet medical need and strive to provide improved patient benefit by delivering targeted, long-lasting activity with fewer side effects. Its lead product candidate, EP-104IAR, is in development for the treatment of pain due to osteoarthritis of the knee. In addition, it is developing a pipeline of earlier-stage long-acting formulations. Show more

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
www.eupraxiapharma.com
Headquarters
Victoria, British Columbia, Can
Founded
-
Eupraxia Pharmaceuticals Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker EPRX. The last closing price for Eupraxia Pharmaceuticals was $3.60. Over the last year, Eupraxia Pharmaceuticals shares have traded in a share price range of $ 2.20 to $ 4.08.

Eupraxia Pharmaceuticals currently has 35,622,553 shares outstanding. The market capitalization of Eupraxia Pharmaceuticals is $128.24 million. Eupraxia Pharmaceuticals has a price to earnings ratio (PE ratio) of -6.35.

Ask ADVFN Intelligence (AI)

EPRX Latest News

More News

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

19 hours ago
Edgar (US Regulatory)

Eupraxia's DiffuSphere™ Technology Demonstrates Targeted Drug Release while Minimizing Systemic Exposure for a Period of More Than Six Months

Eupraxia's DiffuSphere™ Technology Demonstrates Targeted Drug Release while Minimizing Systemic Exposure for a Period of More Than Six Months PR Newswire VICTORIA, BC, Nov. 20, 2024...

21 hours ago
PR Newswire (US)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

November 14 2024
Edgar (US Regulatory)

Eupraxia Pharmaceuticals to Present at American College of Rheumatology Convergence 2024 Annual Meeting

Eupraxia Pharmaceuticals to Present at American College of Rheumatology Convergence 2024 Annual Meeting PR Newswire VICTORIA, BC, Nov. 14, 2024 VICTORIA, BC, Nov. 14, 2024 /PRNewswire/ - Eupraxia...

November 14 2024
PR Newswire (US)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

November 13 2024
Edgar (US Regulatory)

Eupraxia Pharmaceuticals' CEO Dr. James Helliwell to Participate in Webinar Event, "Eosinophilic Esophagitis: The Emerging Digestive Disorder Frequently Misdiagnosed", on November 15, 2024

Eupraxia Pharmaceuticals' CEO Dr. James Helliwell to Participate in Webinar Event, "Eosinophilic Esophagitis: The Emerging Digestive Disorder Frequently Misdiagnosed", on November...

November 13 2024
PR Newswire (Canada)

Eupraxia Pharmaceuticals Announces Positive Data from Fifth Cohort of RESOLVE Phase 1b/2a Trial of EP-104GI for Treatment of Eosinophilic Esophagitis

Eupraxia Pharmaceuticals Announces Positive Data from Fifth Cohort of RESOLVE Phase 1b/2a Trial of EP-104GI for Treatment of Eosinophilic Esophagitis Canada NewsWire VICTORIA, BC, Nov. 12, 2024...

November 12 2024
PR Newswire (Canada)
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.6120.40133779262.994.082.8540883.51904346CS
41.1446.34146341462.464.082.326303713.29965168CS
120.9435.33834586472.664.082.2143643.07092189CS
260.6522.03389830512.954.082.2150912.91193775CS
520.051.408450704233.554.082.2165752.89749301CS
1560.051.408450704233.554.082.2165752.89749301CS
2600.051.408450704233.554.082.2165752.89749301CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
AALAmerican Airlines Group Inc
$ 14.46
(0.00%)
0
AAGRAfrican Agriculture Holdings Inc
$ 0.1326
(0.00%)
0
AADRAdvisorShares Dorsey Wright ADR ETF
$ 67.36
(0.00%)
0
AADIAadi Bioscience Inc
$ 2.22
(0.00%)
0
AACGATA Creativity Global
$ 1.02
(0.00%)
0
AALAmerican Airlines Group Inc
$ 14.46
(0.00%)
0
AAGRAfrican Agriculture Holdings Inc
$ 0.1326
(0.00%)
0
AADRAdvisorShares Dorsey Wright ADR ETF
$ 67.36
(0.00%)
0
AADIAadi Bioscience Inc
$ 2.22
(0.00%)
0
AACGATA Creativity Global
$ 1.02
(0.00%)
0
AALAmerican Airlines Group Inc
$ 14.46
(0.00%)
0
AAGRAfrican Agriculture Holdings Inc
$ 0.1326
(0.00%)
0
AADRAdvisorShares Dorsey Wright ADR ETF
$ 67.36
(0.00%)
0
AADIAadi Bioscience Inc
$ 2.22
(0.00%)
0
AACGATA Creativity Global
$ 1.02
(0.00%)
0

Discussion

View Full Feed
MoneyMaker111 MoneyMaker111 5 minutes ago
GME to close at or above $30 todayyy?

$GME ( Hyper Bullish / Apish )
#GME ( Hyper Bullish / Apish )
GME
infamous infamous 6 minutes ago
thats funny. on otcmarkets they talk about affordable housing. thats a euphomism for cheap homes in getto areas. 100% sure on that description IMO
ATWT
Golfbum22 Golfbum22 25 minutes ago
Hey

Pauljon4

Your village people are calling

They are missing their anger management idiot

Please grow up and do your research before you think you are smarter than anyone here.

Show some respect and stop worrying about pric
FNMA
PC retired PC retired 25 minutes ago
"Entergy" is a real business, and a big one. All the supposed distributors use the name of a real world business with added or subtracted terms, purely intended to deceive. On another note, how is Mr Szilard's install doing?, we have not heard from him in quite a while- we demand an update!!
FLCX
NotSure2 NotSure2 26 minutes ago
Lol, a judge would not be waiting for approval or not of a company before rendering his/her/zer/their etc... judgment.

The worrying part is this:

Since KG is now (always been, deep state establishment) "an ennemy" of Donald Trump, KG now falls into "allie" of the democr
NWBO
ysung ysung 28 minutes ago
Gold FuturesCOMEX: GCW00
style="font-family: "Google Sans", Roboto, "Helvetica Neue", Arial, sans-serif; font-size: 24px;
NBRI
DDA DDA 32 minutes ago
Some smaller amounts going through ... someone is silently pilling up
STGZ
The Danish Dude The Danish Dude 34 minutes ago
I have gone down the alley of dendritic cells and trying to look at alternatives for that time, for a dendritic cell vaccine, that in any way could align with the data in the clinical trial and the results and process covered in the article.

DocLee raises good questions. I have ping-p
NWBO
SkeBallLarry SkeBallLarry 35 minutes ago
Matthew Whitaker is a Great pick Steve Bannon sure is happy about it .. !!
The ELTP King The ELTP King 36 minutes ago
Nasrat promised "at least" two filings by the end of 2024 which means two positive BE studies.

Both BE studies failed.

Now he did say "at least" two filing so maybe the third BE study will actually pass?

Sure would be nice to get another BE or two up to t
ELTP
236T568 236T568 36 minutes ago
BREAKING:

Today’s launch by Russia of an intercontinental ballistic missile against Ukraine is the first time ever an ICBM has been launched at another state in a war.

https://x.com/visegrad24/status/1859515908172960221
TommyJ7651 TommyJ7651 36 minutes ago
I don't think asking Paul about future equity financings will yield much substance. It's not like the guy has a crystal ball and he can tell us exactly how future financing rounds will emerge or what situations we might find ourselves in. He will most likely tell us the same old story about them try
FFMGF
benz280e benz280e 38 minutes ago
Dung_Fart,

Who operates with self appointed importance.

Has spoken, all should take heed...
GDVM
The ELTP King The ELTP King 38 minutes ago
So not only is Nasrat hurting Elite with his Mikah nonsense, he's hurting Elite with his warrant nonsense as well.

The reason warrants are recorded as a liability because it shows the fair value loss the company is realizing during the fiscal period by issuing shares at current share
ELTP
The ELTP King The ELTP King 40 minutes ago
Do you have a learning disability?

They can't FREAKING buy ELTP because their brokerages don't allow it.

Tell everyone you know to tell 10 people to buy $100+ we can start a new MOASS like GME
ELTP GME
Bruno2 Bruno2 41 minutes ago
Nov. 19, 2024 : Nikola leader talks future of hydrogen-powered trucks in US

Nikola trucks are manufactured in Coolidge, Arizona. The company’s fuel cell production is growing each quarter, Clayton said.

The plant was built to produce 30,000 trucks each year. Clayton sai
NKLA
fuagf fuagf 43 minutes ago
Patience and a helping hand, you nailed it. Thks.
The ELTP King The ELTP King 43 minutes ago
You JUST proved my point and other people's points that are of my same mindset.

OF COURSE Nasrat isn't selling anytime soon for the VERY reason you mentioned!

LMAO!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!

The point being the longer
ELTP
LVerstee LVerstee 45 minutes ago
snow. The stupidity is being displayed by your own response. In the fact that you continue to believe in fairytales.
HERB
The ELTP King The ELTP King 47 minutes ago
LMAO.

He can't buy the full 7.5 million shares until January 2026 - OVER a year away.

Like I said, Elite ain't being sold ANY time soon.

It was so obvious and my thoughts are that it will happen after Doug buys those 7 million shares at .03 that are avail
ELTP
PC retired PC retired 49 minutes ago
I would reckon that this is just the tip of the iceberg and many more claims will arrive soon. I remain amazed at the lack of proper DD by these investors/creditors. Proper DD means that if one is not scientifically educated, then the advice of a professional physicist/engineer is an ABSOLUTE MINIMU
ASRE
jrsh jrsh 49 minutes ago
PINK LIMITED....... YIELD SIGN!!!!
GEGR
devil dog 96 devil dog 96 50 minutes ago
WoW the no proof scam theory promoter clowns🤡 went hard promoting their clown show promo tonight!! 😃 Will see if they have any luck tricking anyone out of their shares tomorrow with all the no proof scam theory promo propaganda they spoon feed everyone here tonight. 🤣 LMAO
ATMH

Your Recent History

NASDAQ
EPRX
Eupraxia Pharmaceuticals
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved